The EpiVax team is excited to in-person at AAPS NBC 2022 in Anaheim, CA!
Interested in connecting? Consider stopping by one of our presentations, or say hello to our team at Booth #301 in the exhibit hall!
Additionally, you can request a meeting through the Connect360 portal. Our team would welcome the opportunity to hear about your research, and share the latest from EpiVax on our in silico immunogenicity assessment tools and internal research programs.
Presentations:
Brian Roberts, PhD
Scientific Director, Protein Therapeutics
Keynote: Developing a Peptide T Cell Epitope-Based COVID19 Vaccine
Tuesday, May 10, 2022
1:30 PM – 2:30 PM
Posters:
Brian Roberts, PhD
Scientific Director, Protein Therapeutics
Immunogenicity Risk Assessment for Host Cell Proteins in Vaccines and Biologics. (W1130-01-01)
